✦ LIBER ✦

C-Reactive Protein Level and the Incidence of Eligibility for Statin Therapy: The Multi-Ethnic Study of Atherosclerosis

✍ Scribed by Devin M. Mann; Daichi Shimbo; Mary Cushman; Susan Lakoski; Philip Greenland; Roger S. Blumenthal; Erin D. Michos; Donald M. Lloyd-Jones; Paul Muntner

Book ID: 115554553
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 105 KB
Volume: 36
Category: Article
ISSN: 0160-9289
DOI: 10.1002/clc.22046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraindividual variability of C-reactiv

Intraindividual variability of C-reactive protein: The Multi-Ethnic Study of Atherosclerosis

✍ Emil M. deGoma; Benjamin French; Richard L. Dunbar; Matthew A. Allison; Emile R. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 466 KB

Antihypertensive Medications and C-React

Antihypertensive Medications and C-Reactive Protein in the Multi-Ethnic Study of Atherosclerosis

✍ Walter Palmas; Shuangge Ma; Bruce Psaty; David C. Goff Jr.; Christine Darwin; R. 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 122 KB

Physical Activity and High-Sensitivity C

Physical Activity and High-Sensitivity C-Reactive Protein: The Multi-Ethnic Study of Atherosclerosis

✍ Darcy S. Majka; Rowland W. Chang; Thanh-Huyen T. Vu; Walter Palmas; Dominic F. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 188 KB

The Relationship Between Blood Pressure

The Relationship Between Blood Pressure and C-Reactive Protein in the Multi-Ethnic Study of Atherosclerosis (MESA)

✍ Susan G. Lakoski; Mary Cushman; Walter Palmas; Roger Blumenthal; Ralph B. D’Agos 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Relationship Between C-Reactive Protein

Relationship Between C-Reactive Protein Levels and Regional Left Ventricular Function in Asymptomatic Individuals: The Multi-Ethnic Study of Atherosclerosis

✍ Boaz D. Rosen; Mary Cushman; Khurram Nasir; David A. Bluemke; Thor Edvardsen; Ve 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 233 KB

ELIGIBILITY FOR POLYPILL THERAPY, SUBCLI

ELIGIBILITY FOR POLYPILL THERAPY, SUBCLINICAL ATHEROSCLEROSIS, AND CARDIOVASCULAR EVENTS – NATIONAL IMPLICATIONS FOR THE APPROPRIATE USE OF PREVENTIVE PHARMACOTHERAPY: MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA)

✍ Bittencourt, Marcio Sommer; Blaha, Michael; Blankstein, Ron; Vargas, Jose; Budof 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 344 KB